MabCure Valuation
| MBCI Stock | USD 0.0001 0.00 0.00% |
MabCure seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of MabCure from analyzing the firm fundamentals such as Return On Equity of -1.25, shares outstanding of 64.36 M, and Operating Margin of (1.42) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MabCure's price fluctuation is very steady at this time. Calculation of the real value of MabCure is based on 3 months time horizon. Increasing MabCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MabCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MabCure Pink Sheet. However, MabCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of MabCure's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence MabCure's stock price.
Estimating the potential upside or downside of MabCure helps investors to forecast how MabCure pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MabCure more accurately as focusing exclusively on MabCure's fundamentals will not take into account other important factors: MabCure Total Value Analysis
MabCure is now forecasted to have valuation of 643.64 K with market capitalization of 643.64 K, debt of 304.98 K, and cash on hands of 146.44 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the MabCure fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
643.64 K | 643.64 K | 304.98 K | 146.44 K |
MabCure Investor Information
The company has price-to-book ratio of 0.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MabCure recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. The firm had 20:1 split on the 26th of November 2007. Based on the measurements of operating efficiency obtained from MabCure's historical financial statements, MabCure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.MabCure Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MabCure has an asset utilization ratio of 10.39 percent. This signifies that the Company is making $0.1 for each dollar of assets. An increasing asset utilization means that MabCure is more efficient with each dollar of assets it utilizes for everyday operations.MabCure Profitability Analysis
The company reported the previous year's revenue of 500 K. Net Loss for the year was (12.26 M) with profit before overhead, payroll, taxes, and interest of 500 K.About MabCure Valuation
An absolute valuation paradigm, as applied to MabCure Pink Sheet, attempts to find the value of MabCure based on its fundamental and basic technical indicators. By analyzing MabCure's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of MabCure's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of MabCure. We calculate exposure to MabCure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MabCure's related companies.MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.
8 Steps to conduct MabCure's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MabCure's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MabCure's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MabCure's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MabCure's revenue streams: Identify MabCure's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MabCure's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MabCure's growth potential: Evaluate MabCure's management, business model, and growth potential.
- Determine MabCure's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MabCure's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
MabCure Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 62.1 M | |
| Retained Earnings | -15.5 M |
Complementary Tools for MabCure Pink Sheet analysis
When running MabCure's price analysis, check to measure MabCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MabCure is operating at the current time. Most of MabCure's value examination focuses on studying past and present price action to predict the probability of MabCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MabCure's price. Additionally, you may evaluate how the addition of MabCure to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |